Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05065840 · ClinicalTrials.gov registry record · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
A NA study of Human Papilloma Virus and Human Papilloma Virus Vaccine, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 365
- Enrollment target
- 4
- Study locations
NCT05065840 is a NA study of Human Papilloma Virus and Human Papilloma Virus Vaccine that is actively recruiting participants, run by Emory University. The registered enrollment target is 365 participants, below the 610-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (40% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT05065840, a NA study of Human Papilloma Virus and Human Papilloma Virus Vaccine, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 365 participants
- Enrollment target
- 4
- Study locations
Study Summary
People living with HIV (PLWH) are 28 times more likely to be diagnosed with Human Papillomavirus (HPV) - associated anal cancer than the general population. The HPV vaccine is an effective and safe approach to prevent and reduce the risk of HPV-related disease among PLWH. HPV vaccine programs tailored and implemented in the HIV population are lagging for this high-risk group. The CDC's 4 Pillars Transformation Program is a multi-level, evidence-based intervention that has been successfully used to increase HPV vaccination in the general population and is ready to be tested in the high-risk HIV population, particularly PLWH in the rural South. This program offers providers and clinic staff evidence-based strategies to increase HPV vaccination uptake via training and educational resources. This study proposes to tailor and refine the 4 Pillars Program and conduct this project in three HIV clinics in Georgia.
Conditions Studied
Interventions
- BEHAVIORAL CDC 4 Pillars Program
Study Locations (4)
Georgia
- Albany Rural Model Clinic - Albany
- AID Atlanta - Atlanta
- Faebris - Atlanta
- AHF Lithonia - Lithonia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2023-05-22 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05065840
The ClinicalTrials.gov registry entry for NCT05065840 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 365 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 610-participant average among 26 other Human Papilloma Virus trials with a reported enrollment target (40% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Human Papilloma Virus appearing as the primary indexed condition, and to 1 intervention - of which CDC 4 Pillars Program is the first listed.
NCT05065840 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT05065840 about?
NCT05065840 is a clinical study titled "Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study". People living with HIV (PLWH) are 28 times more likely to be diagnosed with Human Papillomavirus (HPV) - associated anal cancer than the general population. The HPV vaccine is an effective and safe approach to prevent and reduce the risk of HPV-related disease among PLWH. HPV vaccine programs tailor...
What is the current status of trial NCT05065840?
This trial is currently recruiting. It is a NA study. The enrollment target is 365 participants. The study started on 2023-05-22. Estimated completion is 2027-06-01.
What conditions does trial NCT05065840 study?
This clinical trial studies the following conditions: Human Papilloma Virus, Human Papilloma Virus Vaccine.
What interventions are being tested in trial NCT05065840?
The interventions under investigation include: CDC 4 Pillars Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05065840?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05065840 being conducted?
This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Human Papilloma Virus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
RECRUITING · NA
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Impact of Standing Orders Optimization
ACTIVE NOT RECRUITING · NA
-
Development of a Self-collection Device for Cervical Cancer Screening
ACTIVE NOT RECRUITING · NA
-
Impact of Financial Incentives
ACTIVE NOT RECRUITING · NA
-
TORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.